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ABSTRACT
Objective: To establish the prevalence and factors that determine serostatus disclosure 
to sexual partners among HIV infected women. 
Design: Hospital-based cross-sectional study. 
Setting: Patient’s Support Centre (PSC) and Prevention of Mother-To-Child (PMTCT) 
clinic in Kisii District Hospital, Western Kenya.
Subjects: Three hundred and four seropositive women attending PSC and PMTCT 
clinics.  
Results: The 304 respondents interviewed aged between 18-62 years (mean = 32.4 + 
7.5). A large majority (67.8%) had disclosed their serostatus to their sexual partners. 
Of the 32.2% respondents who had not disclosed a high proportion (68.8%) reported 
they had no intention of ever disclosing to the partners. The majority (46.9%) of these 
respondents feared their partners may either abandon them or accuse them of infidelity 
(20.8%). However, this was seldom realised as reported by most respondents who had 
disclosed. The length of time the respondents had lived with the sexual partner and 
knowledge in the benefits of disclosure emerged as significant factors to disclosure 
(OR= 6.20; 95% CI 2.26-17.3; OR=4.88; 95% CI 2.08-11.44) respectively. 
Conclusion: Of the respondents who had not disclosed, a substantial proportion 
reported no intention of disclosing to the partners highlighting various fears. This was 
found to be premised on negative depiction as many respondents who had disclosed 
reported they rarely experienced reprisal from their sexual partners. 
INTRODUCTION
Human Immunodeficiency Virus (HIV) infection is 
one of the greatest challenges facing public health 
since 1980’s. This is due to its massive spread and lack 
of effective treatment or preventive vaccine. Women 
form the vast majority of the 33 million people infected 
globally. By the end of 2006, 48% of all HIV infected 
persons worldwide were women, with 59% being 
in sub-Saharan Africa (1).  In Kenya, 8.7% women 
are infected compared to 5.6% of men (2).  Efforts 
to curb the infection have emphasised the need for 
HIV serostatus disclosure as an important strategy 
to prevent and control the HIV pandemic. However, 
the rate of disclosure is low more so among women. 
This makes HIV prevention and control targets far 
from being optimised (3).  
 Studies conducted in both developed and 
developing countries among women show a disparity 
in the rate of disclosure that ranges between 58-100% 
and 16-84% respectively (4). For instance a study 
conducted in USA (5) found 92% of HIV seropositive 
women had disclosed their status to their sexual 
partners. Elsewhere a study in Tanzania (6) found 
only 31% of HIV-positive women from a VCT clinic 
had disclosed their test results to their partners three 
months after HIV testing. A study conducted in Kenya, 
(7) found that 68% of HIV positive women enrolled in 
Mother-To-Child Transmission (MTCT) trial had not 
disclosed their test results to their sexual partners two 
months after diagnosis and 76% had no intention of 
doing so. Low literacy level and lack of employment 
that result to poor economic status have been cited 
as some of the factors that may deter most women in 
Africa from disclosing their HIV serostatus to their 
sexual partners (8). 
 The consequences have been low uptake and 
adherence to anti-retroviral prophylaxis, unsafe sexual 
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practices and poor psychological health. Prevention 
of Mother-To-Child Transmission (PMTCT) also 
becomes difficult for women who fail to disclose 
their HIV serostatus to their sexual partners (9). 
 Studies carried out in Kenya are few and are 
often carried out on antenatal mothers. This leaves 
the problem of non-disclosure among women poorly 
understood and efforts in prevention and control 
of HIV infection among women far from being 
optimised. This study therefore aims to investigate 
the rate and determinants of serostatus disclosure 
to sexual partners among seropositive women in 
Kenya. Data obtained may be important in guiding 
the programmes on HIV prevention and control. 
MATERIALS AND METHODS
This was a hospital-based cross-sectional study 
conducted in Kisii district hospital located in Kisii 
District in Western Kenya. Kisii is a rural district with 
a population of 352,600 persons. The overall HIV 
prevalence is 7.4% with women having a higher rate 
of infection (5.1%) compared to men (3.2%). This has 
continued to be a big challenge to the district as the 
pandemic have largely strained the socio-economic 
sector due to a high number of widows and orphans 
(10). The hospital is the only tertiary health facility in 
the district that is government owned and receives 
medical referrals from surrounding health facilities.
 Sample size was determined by Fisher’s et al., 
(1998) method and a sample size of 304 respondents 
was realised. Respondents were then proportionally 
sampled from two study units in the hospital 
namely; Prevention of Mother-To-Child Transmission 
(PMTCT) clinic (33 respondents) and Patient’s Support 
Centre (PSC) that provided comprehensive medical 
care for persons with HIV infection (271 respondents). 
The study population included only women aged 18 
years and above, with sexual partner(s) and diagnosed 
as HIV seropositive at least 30 days before the time 
of study. Systematic sampling was used to select 
respondents as they left the study sites and data were 
collected quantitatively for a period of 16 days. All 
the respondents affirmed to have received post-test 
counselling on disclosure at one time of their clinic 
attendance.
 In this study, disclosure meant having told the 
current sexual partner(s) of HIV seropositive status by 
the time of the interview. A sexual partner was defined 
as the present female's male partner(s) whether 
legitimate or otherwise. Informed verbal consent was 
first obtained from all the sampled respondents. They 
were then interviewed by trained research assistants 
in private rooms by use of a pre-tested structured 
interviewer’s schedule. Each interview session was 
done in the respondent’s language of choice (Gusii, 
Swahili or English) and lasted approximately 20-30 
minutes. 
 The variables included in the study were; socio-
demographic factors and HIV related characteristics 
of the respondents (age, marital status, level of 
education, employment status, religion, time since 
the respondent was HIV diagnosed and the reason 
that prompted HIV testing). Respondents were also 
asked the socio-demographic factors and HIV related 
characteristics of their sexual partners. 
Knowledge in relation to disclosure as well as 
involvement in social support groups were also 
examined. All the information was written in English. 
Ethical approval for the study was obtained from 
both Maseno University research committee and 
the study hospital. Confidentiality was assured and 
ensured by keeping the identities of the participants 
anonymous and the information given confidential 
to only the study team. 
 Data collected were entered and analysed by 
Statistical Application Software (SAS) Univariate, 
bivariate and multivariate analyses were carried 
out. Univariate analysis involved summarising the 
data using tables of frequencies, means, proportions, 
confidence intervals and standard deviations. 
Bivariate analysis was then done which explored 
determinants of disclosure. All the significant 
variables (P ≤ 0.05) in this analysis were then entered 
in to a single model for multivariate analysis and 
logistic regression test carried out to identify the 
predictor variables. 
RESULTS
Study population: Respondents aged between 18-62 
years (mean age 32.4 + 7.5 years). Most of them (79.3%) 
were married and about a half (48%) were of primary 
education level. About 61% were unemployed. The 
mean time since the respondents were HIV diagnosed 
was 1.6 years and ranged between 1.3 months to 9 
years. Slightly above half of the respondents (54.3%) 
were living with their sexual partners and most of 
them (53.8%) had lived together for more than seven 
years. About half of the respondent’s sexual partners 
(52%) had gone for HIV testing of whom 81% had 
tested seropositive (Table 1). 
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Table 1
Socio-demographic and HIV related characteristics of the respondents 
Variable  No. (%) 
Age 
 ≤ 20 years   6(2.0) 
 21–30 years        130(42.8) 
 31-40 years                                                                123(40.4)     
 41 – 50 years  41(13.5)
 51+ years   4(1.3)
Marital status  
 Married 241(79.3)
 Never married                                           13(4.3) 
 Widow  32(10.5)
 Divorced/separated  18(5.9) 
Level of education 
 None  16(5.3) 
 Primary  146(48.0) 
 Secondary  104(34.2) 
 Post secondary 38(12.5) 
Employment status 
 Employed  118(38.8)
 Not employed  186(61.2) 
Duration since HIV diagnosed 
 <1 year  131(43.1)
 1–3 years   151(49.7)
 4-7 years  15(4.9)
 >7 years                                                                        (2.3)
Reason for taking HIV test  
 Know serostatus  31(10.2)
 Mandatory for medical care       67(22.0) 
 Frequent ill health  155(51.0) 
 Sexual partner had tested HIV +ve 36(11.8) 
 Child was sick  15(5.0) 
Duration lived with the sexual partner 
 <1 year                             23(7.6) 
 1–3 years  59(19.5)
 4–7 years 58(19.1)  
 >7 years   163(53.8) 
Living together with the sexual partner 
 Yes           165(54.3) 
 No   139(45.7) 
Sexual partner’s serostatus* * n= 158 for this variable
 Positive   128(81.01)
 Negative    30(8.99) 
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Rate of disclosure: Respondents were asked whether 
they had disclosed their HIV serostatus to their sexual 
partners by the time of study. Further enquiries 
were made on how long it took to disclose among 
the respondents who reported to have disclosed. 
A significant proportion [(67.8%) 206] reported to 
have disclosed. Out of this proportion, nearly three 
quarters [(72.8%) 150] had disclosed in less than seven 
days following diagnosis, while 16% (33) disclosed 
30 days after they were HIV diagnosed. Of the 32.2% 
(98) who had not disclosed, 68.8% (67) said they had 
no intention of ever disclosing.  
What determined disclosure: The effect of socio-
demographic and HIV related characteristics of the 
respondents was studied against disclosure (Table 2). 
The study found a significance association between 
disclosure and the duration of living together. 
Respondents who had lived with the partner for 
more than seven years were 6.2 times [OR 6.2; 95% 
CI: 2.26-17.3] more likely to disclose than those who 
had lived together for less than one year (P = 0.001). 
Similarly, the nature of living mattered. Respondents 
who were living together with the sexual partner were 
1.83 times more likely [OR 1.83; 95% CI: 1.07-3.12] 
to disclose compared to those not living together (P 
= 0.001). 
Table 2 
Statistically significant variables associated with disclosure at multivariate analysis
Variable OR 95% CI P-value   
Living  together with the sexual partner 1.83 1.07-3.12          0.001
More than 7 years living with the sexual partner 6.20 2.26-17.3          0.001  
Knowledge on disclosure benefits 4.88 2.08-11.44       0.000  
Sexual partner’s seropositive status 2.98 1.07-8.36         0.009  
Being a member of social support groups 3.28 1.14-9.47         0.040
Reasons for disclosure: Most of the respondents (26.2%) 
felt disclosure was a collective liability between 
a woman and her sexual partner and therefore 
felt compelled to disclose while 24.3 and 20.9% 
respectively disclosed to either challenge their 
partners to get HIV tested or with an anticipation 
of getting social support. Upon further probe on 
how the partner reacted upon disclosure, most 
respondents (75.7%) reported their partners had 
supported them. Only 2.4 and 2.9% respectively 
said either their partners chased them away or they 
usually maltreat them.      
Reasons for non disclosure: Of the respondents (32.2%) 
who had not disclosed, the majority, (68.8%) said they 
had no intention of ever disclosing their status to their 
sexual partners. The larger proportion reported fears 
of being abandoned (46.9%), accused of infidelity 
(20.8%), being chased out or being beaten (14.6%). 
Knowledge: On analysis of knowledge against 
disclosure, the study established that; knowing 
the benefits associated with disclosure was likely 
to influence disclosure. Respondents who knew the 
benefits of disclosing HIV seropositive status to sexual 
partners (90.1%) were 4.88 times more likely [OR 4.88; 
95% CI: 2.08-11.44] to disclose as compared to those 
who said they did not know any benefit (P = 0.000).  
HIV related characteristics of the sexual partner: The 
study further looked at HIV related characteristics of 
the respondent’s sexual partner to find out whether 
they determined disclosure. The analysis showed that; 
respondents whose sexual partners had tested HIV 
seropositive were 2.98 times more likely [OR 2.98; 
95% CI: 1.07-8.36] to disclose than those whose sexual 
partners had tested seronegative (P = 0.009).
Social support groups: Involvement in social support 
groups was lastly assessed to establish whether there 
was any relationship with disclosure. The results 
were that social support groups indeed determined 
disclosure. Respondents who were members of social 
support groups were 3.28 times more likely [OR 3.28; 
95% CI: 1.14-9.47] to disclose to their sexual partners 
than those not in social support groups (P = 0.009).
DISCUSSION
The rate of serostatus disclosure to sexual partners 
among HIV infected women in this study was high 
compared to non-disclosure. Most respondents 
disclosed in less than seven days after HIV diagnosis. 
An important aspect however is respondents who 
reported not to have disclosed and had no intention of 
ever disclosing for they remain a continuous source of 
infection to their sexual partners and/or at risk of HIV 
re-infection. A high proportion of the respondents who 
had not disclosed alleged that, disclosure was a risky 
endeavor and as such they feared being abandoned, 
accused of infidelity, withdrawal of economic support, 
being chased away or being beaten by their sexual 
partners. Similar studies (11,12) conducted in other 
African countries produced the same findings. 
Among the respondents who had disclosed, majority 
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reported they were aggravated to do so since they 
knew their partners were also seropositive thus 
perceiving the reactions of the partner less formidable. 
Others said they disclosed for they felt the partner 
was to blame for their HIV infection while a smaller 
proportion disclosed to either prompt their partners 
to undertake a HIV test or with an anticipation of 
getting social support. 
These results are consistent with findings of a study 
(13), which found higher disclosure rates between 
seropositive couples as compared to serodiscordant 
ones. Disclosure among most study subjects in the 
study was meant to elicit various forms of support.
 This study found disclosure advancing with the 
duration the respondent had lived with the sexual 
partner and also with the nature of living. The longer 
the respondent had lived with the partner, the higher 
there was a probability of disclosing. This was also 
the case of those partners who were living together. 
It is probable these two types of respondents could 
have grown to be confidants with their partners or 
they may have opted to tell someone for emotional 
and social support and the sexual partner happened 
to be in their precincts.  Alternatively, the respondents 
could have been impelled to disclose in the interest 
of taking HIV drugs or attending medical treatment. 
They may have also felt less likely to be accused 
of infidelity resulting to less fear to reprisal upon 
disclosure. This observation alluded with another 
study (14) where women who had stayed with their 
partners for more than two years were more likely 
to disclose than those who had stayed together for 
a shorter period of time.  However, a similar study 
(15) did not find this relationship. 
 When those who had disclosed were asked 
their partner’s reaction after they told them their 
serostatus, majority reported their partners were 
supporting them and only a few said their partners 
had either chased them away or had beaten them. This 
indicates that, the anticipated fears the respondents 
had on disclosing to their sexual partners were seldom 
realised. It is possible then, respondents who had 
not disclosed perceived the risk of negative outcome 
more immense than it actually was. 
 There was a correlation between knowledge and 
disclosure as respondents who knew the benefits 
associated with disclosure were more likely to disclose 
compared to those who did not know. This was in spite 
of of the level of education. A study (16) stated that, 
poor or lack of knowledge on the benefits associated 
with disclosure often results to underestimation of 
disclosure as a strategy to curb HIV spread. This 
may have been the case among the respondents who 
had not disclosed in this study. Although there were 
counselling sessions on disclosure to sexual partner(s), 
conducted at the study sites with every new client, 
these sessions were not consistent and there were 
no follow ups. Most clients may have thus down 
played the significance of disclosure or the new HIV 
experience may have impaired their perception. 
 A higher rate of disclosure among respondents 
who were involved in social support groups highlights 
the significance of such groups. Respondents who 
were members of social support groups said they 
had no worries about social isolation, stigmatisation 
and rejection thus these factors may have enhanced 
disclosure. An earlier study (14) conducted in 
Tanzania also found more disclosure rates among 
HIV infected women who were in self-help groups. 
In conclusion non disclosure was found to be premised 
on negative depiction as many respondents who 
had disclosed said they rarely experienced reprisal 
from their sexual partners. However, it is pertinent 
to note most of the respondents who disclosed had 
seropositive partners and this may have enhanced 
their disclosure.        
Recommendation: The proportion of respondents who 
had not disclosed and had no intention of disclosing 
to their sexual partners cannot be downplayed hence 
this study recommends a need to create forums for 
HIV seropositive persons  at medical setups so as 
to share experiences that may be relevant to those 
who had not disclosed. An intensive campaign that 
promotes HIV testing and counselling between sexual 
partners may also be used to overcome the upheavals 
of non disclosure. These may not only intensify 
interventional measures that address non-disclosure 
among sexual partners, but may also subsequently 
uphold HIV prevention and control efforts.
Limitations: The prevalence and factors that 
determined disclosure in this study may not be 
extrapolated among all HIV infected women since 
respondents in this study were recruited at publicly 
funded hospital mandated to provide free services. It 
is therefore more likely that they were predominantly 
of low socio-economic status with a different approach 
to issues of disclosure.
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